Cancer Drug Parity Act of 2025
U.S. Congress · HR4101 ·
Introduced
In Committee
Reported
Floor
Passed Chamber
Enacted
What the bill says
Introduced 2025-06-24. Latest action: Referred to the House Committee on Education and Workforce.
Sponsors
- Glenn Grothman (primary)
- Gus M. Bilirakis
- Suzanne Bonamici
- Julia Brownley
- Becca Balint
- Janelle S. Bynum
- Robert P. Bresnahan, Jr.
- Ed Case
- Kathy Castor
- Herbert C. Conaway, Jr.
- Donald G. Davis
- Sharice Davids
- Brian K. Fitzpatrick
- John Garamendi
- Chrissy Houlahan
- Jonathan L. Jackson
- Timothy M. Kennedy
- Gwen Moore
- Doris O. Matsui
- Joseph D. Morelle
- Eleanor Holmes Norton
- Joe Neguse
- Chris Pappas
- Deborah K. Ross
- Jamie Raskin
- Andrea Salinas
- Derek Schmidt
- Eugene Simon Vindman
- Joe Wilson
Text versions
- Introduced in House — 2025-06-24 — XML
What analysts say
No nonpartisan analysis on file for this measure yet.
What politicians say
No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.
Action History
| Date | Action |
|---|---|
| 2025-06-24 | Introduced in House |
| 2025-06-24 | Referred to the House Committee on Education and Workforce. |
Lobbying on this bill
Showing 3 of 3 bill mentions.
Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.
| Registrant (lobbying firm) | Client | Period | Reported quarterly amount | Extraction |
|---|---|---|---|---|
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | Q2 2026 | $480,000 | |
| CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION | Q2 2026 | $50,000 | |
| ASSOCIATION FOR CLINICAL ONCOLOGY | ASSOCIATION FOR CLINICAL ONCOLOGY | Q1 2026 | $210,000 |
Source: Senate LDA filings.